View in EDS

Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer.
Authors: Kung CP; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Cottrell KA; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Ryu S; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Bramel ER; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Kladney RD; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Bao EA; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Freeman EC; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Sabloak T; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Maggi L Jr; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Weber JD; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA. jweber@wustl.edu.; Department of Cell Biology and Physiology, Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO, USA. jweber@wustl.edu.
Source: Oncogene [Oncogene] 2021 Jan; Vol. 40 (1), pp. 189-202. Date of Electronic Publication: 2020 Oct 27.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33110236
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kung+CP%22">Kung CP</searchLink>; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Cottrell+KA%22">Cottrell KA</searchLink>; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Ryu+S%22">Ryu S</searchLink>; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Bramel+ER%22">Bramel ER</searchLink>; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Kladney+RD%22">Kladney RD</searchLink>; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Bao+EA%22">Bao EA</searchLink>; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Freeman+EC%22">Freeman EC</searchLink>; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Sabloak+T%22">Sabloak T</searchLink>; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Maggi+L+Jr%22">Maggi L Jr</searchLink>; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Weber+JD%22">Weber JD</searchLink>; Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, Saint Louis, MO, USA. jweber@wustl.edu.; Department of Cell Biology and Physiology, Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO, USA. jweber@wustl.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228711562%22">Oncogene</searchLink> [Oncogene] 2021 Jan; Vol. 40 (1), pp. 189-202. <i>Date of Electronic Publication: </i>2020 Oct 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8711562 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5594 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209509232%22">09509232 </searchLink><i>NLM ISO Abbreviation: </i>Oncogene <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33110236
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41388-020-01515-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 189
    Titles:
      – TitleFull: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kung CP
      – PersonEntity:
          Name:
            NameFull: Cottrell KA
      – PersonEntity:
          Name:
            NameFull: Ryu S
      – PersonEntity:
          Name:
            NameFull: Bramel ER
      – PersonEntity:
          Name:
            NameFull: Kladney RD
      – PersonEntity:
          Name:
            NameFull: Bao EA
      – PersonEntity:
          Name:
            NameFull: Freeman EC
      – PersonEntity:
          Name:
            NameFull: Sabloak T
      – PersonEntity:
          Name:
            NameFull: Maggi L Jr
      – PersonEntity:
          Name:
            NameFull: Weber JD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2021 Jan
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5594
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Oncogene
              Type: main
ResultId 1